HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Inovio Pharmaceuticals, Inc. (INO)
11.35  -0.5  (-4.22%) 10-19 20:28
Open: 11.9 High: 11.98
Pre.close: 11.85 Low: 11.25
Volume: 5,265,686 Ave vol: 19,820,348
52w High: 33.79 52w Low: 2.09
MA(50): 12.76 MA(200): 15.174
EPS: -1.852 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.inovio.com/
Market Cap (M): 1,901
Shares Out (M): 168
Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. The company is headquartered in San Diego, California and currently employs 281 full-time employees. The firm's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. The company has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.
Technical analysis
Overall: Underperform
MA: Bearish MACD: Bearish
KDJ: Bearish RSI: Bearish
Target 1: 18.08 Target 2: 21.83
Resist 1: 15.48 Resist 2: 18.69
Support 1: 10.28 Support 2: 8.55
Company key metrics
Revenue per Share: 0.0417
Net Income per Share: -1.2091
Cash per Share: 0.2248
Book Value per Share: 0.0348
Price to Sales: 111.8759
Price to Book Value: 133.9192
Earnings Yield: -0.2595
Dividend Yield: 0
Debt to Equity: 40.9061
Debt to Assets: 0.9761
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.